FibroBiologics Financial Statements 2021-2024 | FBLG

Fifteen years of historical annual and quarterly income statements for FibroBiologics (FBLG).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM202320222021
$0.00$0$0$0
$0.00$0$0$0
$0.00$0$0$0
$2.48$2.37$1.15$0.52
$6.29$6.52$3.32$1.06
$0.00$0$0$0
$0.00$0$0$0
$-8.77$-8.89$-4.47$-1.58
$-0.96$-7.60$-0.65$0.00
$-9.72$-16.49$-5.12$-1.58
$0.00$0$0$0
$-9.72$-16.49$-5.12$-1.58
$0.00$0$0$0
$-9.72$-16.49$-5.12$-1.58
$0.00$0$0$0
$-9.72$-19.06$-5.12$-1.58
$-8.39$-8.37$-3.98$-1.58
$-8.77$-8.89$-4.47$-1.58
$-0.32$-0.68$-0.18$0
$-0.32$-0.68$-0.18$0.00

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-312021-12-31
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0.98$0.96$0$0.55$0.48$0$0
$2.25$2.49$0$1.55$1.79$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$-3.22$-3.45$0$-2.09$-2.27$0$0
$4.12$-5.01$0$-0.07$-0.15$0$0
$0.90$-8.46$0$-2.16$-2.42$0$0
$0$0$0$0$0$0$0
$0.90$-8.46$0$-2.16$-2.42$0$0
$0$0$0$0$0$0$0
$0.90$-8.46$0$-2.16$-2.42$0$0
$0$0$0$0$0$0$0
$0.90$-8.46$0$-2.16$-4.99$0$0
$-3.08$-3.31$0$-1.99$-2.09$0$0
$-3.22$-3.45$0$-2.09$-2.27$0$0
$0.03$-0.27$0$-0.08$-0.18$0$0
$0.03$-0.27$0.00$-0.08$-0.18$0.00$0.00